10-Q: Green Planet Bioengineering Reports Q3 2025 Loss

Green Planet Bioengineering Co., Ltd. filed its Q3 2025 10-Q, reporting continued net losses and a significant working capital deficit as a non-operating shell company.

Summary

• The company operates as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation.
• For the nine months ended September 30, 2025, the company reported a net loss of $19,544, compared to a net loss of $22,753 for the same period in 2024.
• For the three months ended September 30, 2025, the net loss was $8,599, an increase from $5,425 for the same period in 2024.
• As of September 30, 2025, the company had no cash, a working capital deficit of $484,678, and an accumulated deficit of $1,114,298.
• The company's operations are entirely financed by a related party of the majority stockholder, with $479,148 due to this related party as of September 30, 2025.
• Management has raised substantial doubt about the company's ability to continue as a going concern, dependent on continued support from the related party.

Sentiment

Score: 2

Explanation: The company is a non-operating shell with no revenue, significant accumulated losses, and a going concern warning. Its entire financial stability relies on a related party, with no clear path to independent operations or profitability. This indicates a highly precarious financial position.

Positives

• Net loss for the nine months ended September 30, 2025, decreased to $19,544 from $22,753 in the prior year, primarily due to reduced administrative expenses.
• Disclosure controls and procedures were evaluated as effective at a reasonable assurance level.

Negatives

• The company has no active business operations and generates no revenue.
• A significant working capital deficit of $484,678 and an accumulated deficit of $1,114,298 as of September 30, 2025.
• Complete reliance on a related party for funding operating expenses, with no independent source of capital.
• The net loss for the three months ended September 30, 2025, increased to $8,599 from $5,425 in the prior year.
• Substantial doubt exists about the company's ability to continue as a going concern.

Risks

• Ability to continue as a going concern is dependent on continued support from a related party, with no assurances of ongoing funding.
• Inability to secure adequate financing from future investors or find profitable business opportunities could delay or prevent the execution of business plans.
• The company's activities are subject to significant risks and uncertainties due to its status as a public reorganized shell corporation with no current business activity.

Future Outlook

The company plans to continue sourcing adequate funding from future investors to execute business opportunities when they arise. However, such funding and business opportunities will rely entirely on prevailing circumstances. If opportunities are not identified in the near term, the company expects delays in effecting its business plans.

Management Comments

• "The Company operates as a public reorganized corporation with the business purpose to acquire or merge with an existing business operation."
• "Going forward, the Company will continue to source adequate funding from future investors to execute business opportunities when they arise in the future."
• "If such opportunities are not identified in the near term, the Company will experience delay in effecting its business plans."
• "The Companys ability to continue as a going concern is dependent on continued support from a related party of Global Funds, a majority stockholder."

Industry Context

As a non-operating shell company, Green Planet Bioengineering Co., Ltd. exists primarily to facilitate a future merger or acquisition. Its financial performance is not indicative of any specific industry trends but rather reflects the costs associated with maintaining public company status while seeking a viable business. The market for shell companies is highly speculative, driven by the potential for future business combinations rather than current operations.

Comparison to Industry Standards

• The company's financial position, characterized by zero revenue, zero cash, and significant accumulated deficits, is typical for a non-operating shell company.
• Reliance on related party funding is a common characteristic for shell entities that lack independent revenue streams or access to traditional capital markets.
• The going concern warning is standard for companies in this stage, highlighting the inherent risks of not having an active business or secured long-term funding.

Corporate Governance

Related Party Transactions

• The company relies on a related party of the majority stockholder to advance funds for operating expenses.
• The amount due to this related party was $479,148 as of September 30, 2025.
• These advances are interest-free, unsecured, and repayable upon demand.
• The company's Chief Executive Officer, Chief Financial Officer, and Director, Jordan Weingarten, is also a director of the related party.
• Subsequent to September 30, 2025, through the filing date, the related party advanced an additional $5,530 to the company.

Stakeholder Impact

• Shareholders face significant risk due to the company's going concern status, lack of operations, and complete reliance on related party funding.
• Potential for future dilution if the company successfully raises capital from new investors.
• Creditors (primarily the related party) bear the risk of the company's inability to generate revenue or secure a profitable business opportunity.

Next Steps

• Identify and acquire or merge with an existing business operation.
• Source adequate funding from future investors to finance business opportunities.

Key Dates

Recommendation

The company is a non-operating shell with a substantial accumulated deficit and a going concern warning. It has no revenue, relies entirely on a related party for funding, and has no identified business opportunities. This presents extreme risk for investors, making it unsuitable for most portfolios due to the high probability of further value erosion or eventual delisting if a viable business combination is not achieved.

Keywords

Shell company, 10-Q, Quarterly report, Going concern, Related party funding, Net loss, Working capital deficit, Bioengineering, Merger acquisition